REPLICor Inc. Announces Four Appointments To Scientific Advisory Board

NEW YORK--(BUSINESS WIRE)--Replicor Inc., a privately held biopharmaceutical company targeting a cure for Chronic Hepatitis B and D patients, today announced the appointments of four clinical experts to its new Scientific Advisory Board. The company has now completed its first series of proof of concept trials and continues to move toward next stage clinical development.

Help employers find you! Check out all the jobs and post your resume.